Skip to content

Multi-electrode electro-anatomical mapping using the Ensite HD Grid Catheter: Activation and repolarization characteristics in human with structural normal hearts and substrate related arrhythmias

Multi-electrode electro-anatomical mapping using the Ensite HD Grid Catheter: Activation and repolarization characteristics in human with structural normal hearts and substrate related arrhythmias - Ensite HD Grid Catheter

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45581
Enrollment
48
Registered
2017-06-28
Start date
2018-01-23
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial en ventricular arrhytmias supraventricular en ventricular rhythm disorders

Interventions

Ablation
electroanatomical mapping
HD Ensite Grid
Multi-elektrode

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Patients who are electively scheduled for a first catheter ablation to treat an atrial of ventricular arrhythmia. - Patient understands the implications of participating in the study and provides informed consent

Exclusion criteria

Exclusion criteria: - Previous surgical of catheter ablation of the atria or ventricle - Patients with uncontrolled heart failure or with NYHA class > II - Patients with stable/unstable angina or myocardial ischemia - Patients with infection - Patients with severe co-morbidity or poor general physical/mental health - Patients with contra - indications for cardiac MRI

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: electrophysiological data, device success, adverse effects and comparability with the current mapping approach and substrate identified by CE-MRI.

Secondary

MeasureTime frame
Not applicable.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)